InnoCare Pharma Ltd. (HK:9969) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
InnoCare Pharma Ltd. has received a one-month waiver from the Hong Kong Stock Exchange to appoint a new independent non-executive director, following the recent resignation of Dr. Kaixian Chen. The company is working to finalize the appointment by the end of January 2025, after facing procedural delays. This move aims to ensure compliance with stock exchange listing rules.
For further insights into HK:9969 stock, check out TipRanks’ Stock Analysis page.